Funded Tech Companies

ArriVent Biopharma

Wondering who provided funding to ArriVent Biopharma? HBM Healthcare Investments, Lilly Asia Ventures and OrbiMed joined the equity holders in this biopharmaceutical company.

Company Overview

Contact Information

Company Background Information

Overview

Arrivent was founded in 2021 with a mission to globally develop top biopharma innovations from around the world to deliver important medicines to patients.Recognizing the plethora of potential first- and best-in-class candidates out of China and other geographic areas such as Europe, South Korea and Japan--and the risk that these might never make it to market due to development challenges in the areas in which they were discovered--we have made it our mission to ensure these innovations get into the hands of patients and physicians across the globe.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

3/27/2023

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Bing Yao

        

Chief Technical Officer

Yang Wang

        

President

Stuart Lutzker

        

Company Investors

• HBM Healthcare Investments
• Lilly Asia Ventures
• OrbiMed
• Catalio Capital Management
• Shanghai Healthcare Capital
• Terra Magnum Capital Partners
• AIHC Capital
• General Catalyst Partners
• Sequoia China
• Sofinnova Partners
• ArriVent Biopharma
• Boyu Capital
• Octagon Capital
• Sirona Capital
• Unicorn Venture Partners
• Infinitum Partners

Browse more funded tech companies:

Arrived Homes | Arrivo

Share this article

About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary